Hetronifly in combination with chemotherapy was shown to improve survival of patients with extensive stage small cell lung ...
Cancer deaths are down in the U.S., but the disease is taking hold in younger populations, likely fueled by obesity, alcohol ...
Researchers investigated differences in T-cell responses between male and female patients with lung cancer that may help direct future treatments. T-cell responses are part of the adaptive immune ...
This episode of the Cancer Horizons podcast features Dr. Jason Porter – a medical oncologist and hematologist at the West ...
In head-to-head clinical trial, Chinese firm Akeso’s ivonescimab beat top-selling drug pembrolizumab sold as Keytruda by Merck. Ivonescimab reduced risk of tumour progression by 49%.
Adjuvant cancer treatments such as chemotherapy and radiation are given after a primary cancer treatment to help prevent ...
Five key safety standards are crucial for preventing occupational lung diseases. Occupational lung diseases occur when ...
The FDA approval of amivantamab-vmjw (Rybrevant) in combination with chemotherapy is the first targeted treatment to cut ...
Merck and Daiichi Sankyo's HER3 antibody-drug conjugate reported a positive phase 3 result in EGFR-mutated lung cancer. Merck ...
Shares of Summit Therapeutics, whose cancer drug candidate turned heads after it outperformed a blockbuster drug from Merck, ...
About 40% of Americans will develop a form of cancer at some point in their lifetime, according to the American Cancer ...
WLNS Lansing on MSN14h
McLaren Greater Lansing using new tool to diagnose lung cancer earlier, more accuratelyRepublican Group Launches Taylor Swift-Themed Ad Attacking Donald Trump A woman lost 159 pounds when she quit strict diets ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback